welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Coxib-inhibition of Duodenal Polyp Growth in FAP
study id #: NCT00844727
condition: Duodenal Polyposis
Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.
start date: September 2003
estimated completion: April 2004
last updated: July 6, 2011
phase of development: Phase 2, Phase 3
size / enrollment: 38
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
- FAP patient with previous colectomy and confirmed polyposis
- NSAID hypersensitivity
sponsor: Oslo University Hospital
trial center locations: Norway
expertly curated content related to this topic
The Genetics of Familial Adenomatous Polyposis (FAP) and MutYH-Associated Polyposis (MAP)FAP is characterized by 100-1000s of ade...
Familial Adenomatous Polyposis and Desmoid TumorsFamilial adenomatous polyposis (FAP) is ...
Starch Powder That can be Sprinkled on Food is Tested as Cure for Bowel CancerA powder made from starch that can b...
Familial Polyposis: Stomach (Dr. Riegert-Johnson)https://www.youtube.com/watch?v=qCEFpBIR...
Cell Proliferation and Apoptotic Indices Predict Adenoma Regression in a Placebo-Controlled Trial of Celecoxib in Fa...BACKGROUND : Celecoxib was shown to regr...
Clinical Management of Hereditary Colorectal Cancer SyndromesHereditary factors are involved in the d...
Intestinal Polyps and Polyposis: State-of-the-Art, Multidisciplinary Publication on Polyps and PolyposisNowadays, we are dealing more frequently...